Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
Moore EC, Blobe GC, DeVito NC, Hanks BA, Harrison MR, Hoimes CJ, Jia J, Morse MA, Jayaprakasan P, MacKelfresh A, Mulder H, Hockenberry AJ, Zander A, Stumpe MC, Michuda J, Beauchamp KA, Perakslis E, Taxter T, George DJ. Moore EC, et al. Among authors: michuda j. Cancer Med. 2023 Oct;12(19):19394-19405. doi: 10.1002/cam4.6532. Epub 2023 Sep 15. Cancer Med. 2023. PMID: 37712677 Free PMC article.
Validation of a Transcriptome-Based Assay for Classifying Cancers of Unknown Primary Origin.
Michuda J, Breschi A, Kapilivsky J, Manghnani K, McCarter C, Hockenberry AJ, Mineo B, Igartua C, Dudley JT, Stumpe MC, Beaubier N, Shirazi M, Jones R, Morency E, Blackwell K, Guinney J, Beauchamp KA, Taxter T. Michuda J, et al. Mol Diagn Ther. 2023 Jul;27(4):499-511. doi: 10.1007/s40291-023-00650-5. Epub 2023 Apr 26. Mol Diagn Ther. 2023. PMID: 37099070 Free PMC article.
Disease diagnostics using machine learning of immune receptors.
Zaslavsky ME, Craig E, Michuda JK, Sehgal N, Ram-Mohan N, Lee JY, Nguyen KD, Hoh RA, Pham TD, Röltgen K, Lam B, Parsons ES, Macwana SR, DeJager W, Drapeau EM, Roskin KM, Cunningham-Rundles C, Moody MA, Haynes BF, Goldman JD, Heath JR, Nadeau KC, Pinsky BA, Blish CA, Hensley SE, Jensen K, Meyer E, Balboni I, Utz PJ, Merrill JT, Guthridge JM, James JA, Yang S, Tibshirani R, Kundaje A, Boyd SD. Zaslavsky ME, et al. Among authors: michuda jk. bioRxiv [Preprint]. 2024 Apr 3:2022.04.26.489314. doi: 10.1101/2022.04.26.489314. bioRxiv. 2024. PMID: 35547855 Free PMC article. Preprint.
Integrated genomic profiling expands clinical options for patients with cancer.
Beaubier N, Bontrager M, Huether R, Igartua C, Lau D, Tell R, Bobe AM, Bush S, Chang AL, Hoskinson DC, Khan AA, Kudalkar E, Leibowitz BD, Lozachmeur A, Michuda J, Parsons J, Perera JF, Salahudeen A, Shah KP, Taxter T, Zhu W, White KP. Beaubier N, et al. Among authors: michuda j. Nat Biotechnol. 2019 Nov;37(11):1351-1360. doi: 10.1038/s41587-019-0259-z. Epub 2019 Sep 30. Nat Biotechnol. 2019. PMID: 31570899
Clinical validation of the tempus xT next-generation targeted oncology sequencing assay.
Beaubier N, Tell R, Lau D, Parsons JR, Bush S, Perera J, Sorrells S, Baker T, Chang A, Michuda J, Iguartua C, MacNeil S, Shah K, Ellis P, Yeatts K, Mahon B, Taxter T, Bontrager M, Khan A, Huether R, Lefkofsky E, White KP. Beaubier N, et al. Among authors: michuda j. Oncotarget. 2019 Mar 22;10(24):2384-2396. doi: 10.18632/oncotarget.26797. eCollection 2019 Mar 22. Oncotarget. 2019. PMID: 31040929 Free PMC article.